retatrutide weight loss phase 2 results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a trial Eli Lilly infiltrates anti-obesity market

Not only does the procedure enhance body contour by creating a more masculine chest, but it also significantly reduces psychological distress caused by excess breast tissue, thereby improving overall well-being

Each batch is accompanied by a Certificate of Analysis (COA) confirming identity, purity, and quality metrics

Aug 14: In what is expected to become a multibillion-dollar blockbuster, Pfizers BCMAxCD3 bispecific antibody Elrexfio (elranatamab-bcmm) has secured an FDA accelerated approval as another off-the-shelf treatment option for patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior lines of therapy

, Turner, C

Estos datos son particularmente relevantes para nuestra regin dado el dramtico incremento del sobrepeso y la obesidad observado en las ltimas dcadas que determinan que uno de cada dos adultos estn en sobrepeso u obesidad 5 , y es bien conocido que el exceso de grasa corporal aumenta el riesgo de DM2 y ECV por inducir, entre otros mecanismos, un estado de resistencia a la insulina, de inflamacin sistmica de bajo grado y por alterar la reactividad vascular 69

(2025, January 28)